Division of Systems Biology, National Center for Toxicological Research, Food and Drug Administration, Jefferson, Arkansas 72079, USA.
Toxicol Sci. 2012 Feb;125(2):335-44. doi: 10.1093/toxsci/kfr321. Epub 2011 Nov 22.
Circulating microRNAs (miRNAs) have emerged as novel noninvasive biomarkers for several diseases and other types of tissue injury. This study tested the hypothesis that changes in the levels of urinary miRNAs correlate with liver injury induced by hepatotoxicants. Sprague-Dawley rats were administered acetaminophen (APAP) or carbon tetrachloride (CCl(4)) and one nonhepatotoxicant (penicillin/PCN). Urine samples were collected over a 24 h period after a single oral dose of APAP (1250 mg/kg), CCl(4) (2000 mg/kg), or PCN (2400 mg/kg). APAP and CCl(4) induced liver injury based upon increased serum alanine and aspartate aminotransferase levels and histopathological findings, including liver necrosis. APAP and CCl(4) both significantly increased the urinary levels of 44 and 28 miRNAs, respectively. In addition, 10 of the increased miRNAs were in common between APAP and CCl(4). In contrast, PCN caused a slight decrease of a different nonoverlapping set of urinary miRNAs. Cluster analysis revealed a distinct urinary miRNA pattern from the hepatotoxicant-treated groups when compared with vehicle controls and PCN. Analysis of hepatic miRNA levels suggested that the liver was the source of the increased urinary miRNAs after APAP exposure; however, the results from CCl(4) were equivocal. Computational analysis was used to predict target genes of the 10 shared hepatotoxicant-induced miRNAs. Liver gene expression profiling using whole genome microarrays identified eight putative miRNA target genes that were significantly altered in the liver of APAP- and CCl(4)-treated animals. In conclusion, the patterns of urinary miRNA may hold promise as biomarkers of hepatotoxicant-induced liver injury.
循环 microRNAs(miRNAs)已成为多种疾病和其他类型组织损伤的新型非侵入性生物标志物。本研究检验了这样一个假设,即尿液 miRNA 水平的变化与肝毒性物质引起的肝损伤相关。Sprague-Dawley 大鼠给予对乙酰氨基酚(APAP)或四氯化碳(CCl(4))和一种非肝毒性物质(青霉素/PCN)。在单次口服 APAP(1250mg/kg)、CCl(4)(2000mg/kg)或 PCN(2400mg/kg)后 24 小时内收集尿液样本。APAP 和 CCl(4) 导致血清丙氨酸和天冬氨酸转氨酶水平升高和组织病理学发现(包括肝坏死)的肝损伤。APAP 和 CCl(4) 分别显著增加了 44 种和 28 种 miRNA 的尿液水平。此外,10 种增加的 miRNA 在 APAP 和 CCl(4) 之间是共同的。相比之下,PCN 导致一组不同的非重叠尿液 miRNA 略有减少。聚类分析显示,与对照组和 PCN 相比,肝毒性物质处理组的尿液 miRNA 模式明显不同。对肝 miRNA 水平的分析表明,APAP 暴露后肝脏是尿液中增加的 miRNA 的来源;然而,CCl(4) 的结果则不确定。计算分析用于预测 10 种共同的肝毒性物质诱导的 miRNA 的靶基因。使用全基因组微阵列进行肝基因表达谱分析,鉴定了 8 个在 APAP 和 CCl(4) 处理动物的肝脏中明显改变的潜在 miRNA 靶基因。总之,尿液 miRNA 的模式可能有望成为肝毒性物质诱导的肝损伤的生物标志物。